Cargando…

Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?

Radical prostatectomy is a leading form of treatment for non metastatic prostate cancer. It has been shown to improve survival in the long term as well as delay or prevent the onset of metastatic disease. However, as the treatment of metastatic prostate cancer has evolved in the last few years with...

Descripción completa

Detalles Bibliográficos
Autor principal: Gautam, Gagan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220371/
https://www.ncbi.nlm.nih.gov/pubmed/25378813
http://dx.doi.org/10.4103/0970-1591.139593
_version_ 1782342720491094016
author Gautam, Gagan
author_facet Gautam, Gagan
author_sort Gautam, Gagan
collection PubMed
description Radical prostatectomy is a leading form of treatment for non metastatic prostate cancer. It has been shown to improve survival in the long term as well as delay or prevent the onset of metastatic disease. However, as the treatment of metastatic prostate cancer has evolved in the last few years with the introduction of newer agents, the possible role of ‘cytoreductive’ radical prostatectomy is now being explored. Preliminary evidence suggests that radical prostatectomy may have a future role in this clinical scenario with a potential to improve quality and quantity of life in selected patients with metastatic disease.
format Online
Article
Text
id pubmed-4220371
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42203712014-11-06 Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer? Gautam, Gagan Indian J Urol Evidence Based Urology Radical prostatectomy is a leading form of treatment for non metastatic prostate cancer. It has been shown to improve survival in the long term as well as delay or prevent the onset of metastatic disease. However, as the treatment of metastatic prostate cancer has evolved in the last few years with the introduction of newer agents, the possible role of ‘cytoreductive’ radical prostatectomy is now being explored. Preliminary evidence suggests that radical prostatectomy may have a future role in this clinical scenario with a potential to improve quality and quantity of life in selected patients with metastatic disease. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4220371/ /pubmed/25378813 http://dx.doi.org/10.4103/0970-1591.139593 Text en Copyright: © Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Evidence Based Urology
Gautam, Gagan
Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title_full Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title_fullStr Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title_full_unstemmed Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title_short Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
title_sort is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
topic Evidence Based Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220371/
https://www.ncbi.nlm.nih.gov/pubmed/25378813
http://dx.doi.org/10.4103/0970-1591.139593
work_keys_str_mv AT gautamgagan isittrulyoutrageoustoconsiderradicalprostatectomyformenwithmetastaticprostatecancer